96
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Nomogram for Estimation of Acute Liver Failure Risk in Spontaneous Ruptured Hepatocellular Carcinoma

, , , &
Pages 2223-2237 | Received 27 Sep 2023, Accepted 05 Dec 2023, Published online: 12 Dec 2023

References

  • Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 3Gut and Liver. Ca a Cancer J Clinicians. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Chan ACY, Dai JWC, Chok KSH, Cheung TT, Lo CM. Prognostic influence of spontaneous tumor rupture on hepatocellular carcinoma after interval hepatectomy. Surgery. 2016;159(2):409–417. doi:10.1016/j.surg.2015.07.020
  • Wang W, Meng T, Chen Y, et al. Propensity score matching study of 325 patients with spontaneous rupture of hepatocellular carcinoma. Hepatobiliary Surgery Nutrition. 2022;11(6):808–821. doi:10.21037/hbsn-21-45
  • Wang P, Yang S, Li C, Han X, Hong D, Shao H. Nomogram-based development and evaluation for predictions of 30-day and 1-year survival in patients with spontaneously ruptured hepatocellular carcinoma. BMC Cancer. 2022;22(1):1177. doi:10.1186/s12885-022-10290-3
  • Xia F, Ndhlovu E, Zhang M, Chen X, Zhang B. Ruptured Hepatocellular Carcinoma: current Status of Research. Front Oncol. 2022;12:848903. doi:10.3389/fonc.2022.848903
  • Kudo M, Kitano M, Sakurai T, Nishida N. General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: the Outstanding Achievements of the Liver Cancer Study Group of Japan. Digestive Dis. 2015;33(6):765–770. doi:10.1159/000439101
  • Huang A, Guo DZ, Wang YP, Fan J, Yang XR, Zhou J. The treatment strategy and outcome for spontaneously ruptured hepatocellular carcinoma: a single-center experience in 239 patients. J Cancer Res Clin Oncol. 2022;148(11):3203–3214. doi:10.1007/s00432-022-03916-3
  • Sahu SK, Chawla YK, Dhiman RK, et al. Rupture of Hepatocellular Carcinoma: a Review of Literature. J Clin Exp Hepatol. 2019;9(2):245–256. doi:10.1016/j.jceh.2018.04.002
  • Lai ECH, Lau WY. Spontaneous rupture of hepatocellular carcinoma: a systematic review. Arch Surg. 2006;141(2):191–198. doi:10.1001/archsurg.141.2.191
  • Zhang SY, Guo DZ, Zhang X, Fan J, Zhou J, Huang A. Prognosis of spontaneously ruptured hepatocellular carcinoma: a propensity score matching study. J Cancer Res Clin Oncol. 2023;149(11):8889–8896. doi:10.1007/s00432-023-04774-3
  • Deng Z, Wang Y. Predictors of liver failure after transarterial chemoembolization in patients with spontaneously ruptured hepatocellular carcinoma: a retrospective study. J Interventional Med. 2023;6(1):35–40. doi:10.1016/j.jimed.2022.10.003
  • Sandomenico F, Arpaia V, De Rosa F, et al. Spontaneously Ruptured Hepatocellular Carcinoma: computed Tomography-Based Assessment. Diagnostics. 2023;13(6). doi:10.3390/diagnostics13061021
  • Miyamoto M, Sudo T, Kuyama T. Spontaneous Rupture of Hepatocellular Carcinoma: a Review of 172 Japanese Cases. Am J Gastroenterol. 1991;86(1):67–71. doi:10.1111/j.1572-0241.1991.tb06831.x
  • Zhang W, Zhang ZW, Zhang BX, et al. Outcomes and Prognostic Factors of Spontaneously Ruptured Hepatocellular Carcinoma. J Gastrointestinal Surgery. 2019;23(9):1788–1800. doi:10.1007/s11605-018-3930-7
  • Obeidat AE, Wong LL. Spontaneous Rupture of Hepatocellular Carcinoma: new Insights. J Clin Exp Hepatol. 2022;12(2):483–491. doi:10.1016/j.jceh.2021.05.010
  • Bouare N. Current management of liver diseases and the role of multidisciplinary approach. World J Hepatol. 2022;14(11):1920–1930. doi:10.4254/wjh.v14.i11.1920
  • Spengler U, Fischer HP, Caselmann WH. Chapter 34 - Liver Disease Associated with Viral Infections. In: Boyer TD, Manns MP, Sanyal AJ, editors. Zakim and Boyer’s Hepatology. 6 ed. W.B. Saunders; 2012:629–643. doi:10.1016/B978-1-4377-0881-3.00034-6
  • Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380. doi:10.1002/hep.29086
  • Sarin SK, Choudhury A, Sharma MK, et al. Correction to: acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(6):826–828. doi:10.1007/s12072-019-09980-1
  • Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1–85.
  • Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646–649. doi:10.1002/bjs.1800600817
  • Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864–871. doi:10.1053/he.2000.5852
  • Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-The ALBI grade. J Clin Oncol off J Am Soc Clin Oncol. 2015;33(6):550–558. doi:10.1200/JCO.2014.57.9151
  • Alliance of Chinese Expert Consensus on Neoadjuvant Therapy for Hepatocellular Carcinoma, Committee of Digestive Surgery of Chinese Research Hospital Association, Committee of Liver Cancer, Chinese Anti‐Cancer Association. 肝癌新辅助治疗中国专家共识(2023版) [Chinese expert consensus on neoadjuvant therapy for hepatocellular carcinoma (2023 edition)]. Zhonghua Wai Ke Za Zhi. 2023;61(12):1–11. Chinese. doi:10.3760/cma.j.cn112139-20230914-00121
  • Moris D, Chakedis J, Sun SH, et al. Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: a systematic review. J Surg Oncol. 2018;117(3):341–353. doi:10.1002/jso.24869
  • Tanaka S, Kaibori M, Ueno M, et al. Surgical Outcomes for the Ruptured Hepatocellular Carcinoma: multicenter Analysis with a Case-Controlled Study. J Gastrointest Surg. 2016;20(12):2021–2034. doi:10.1007/s11605-016-3280-2
  • Cheng YT, Teng W, Lui KW, et al. MELD score is the better predictor for 30-day mortality in patients with ruptured hepatocellular carcinoma treated by trans-arterial embolization. Am j Cancer Res. 2021;11(7):3726–3734.
  • Guo J, Wang W, Zhang Y, Xu L, Kong J. Comparison of initial tumor responses to transarterial bland embolization and drug-eluting beads-transarterial chemoembolization in the management of hepatocellular carcinoma: a propensity-score matching analysis. J gastrointestinal Oncol. 2021;12(4):1838–1850. doi:10.21037/jgo-21-370
  • Zou J, Li C, Chen Y, et al. Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma. Oncol Lett. 2019;18(6):6423–6430. doi:10.3892/ol.2019.11037
  • Chen Y, Guo D, Li X, Xu C, Zhu Q. Predictors of Spontaneous Rupture of Hepatocellular Carcinoma and Clinical Outcomes Following Hepatectomy. Front Oncol. 2022;12:820867. doi:10.3389/fonc.2022.820867
  • Ye F, Ma D, Gong XY, Yang YC, Chen YJ. Development and validation of risk score for predicting spontaneous rupture of hepatocellular carcinoma. Ann Surgical Treatment Res. 2020;99(5):268–274. doi:10.4174/astr.2020.99.5.268
  • Li S, Liu Z, Wu H. The product value of serum albumin and prothrombin time activity could be a useful biomarker for severity prediction in AP: an ordinal retrospective study. Pancreatology. 2019;19(2):230–236. doi:10.1016/j.pan.2019.02.001
  • Qiu Y, Wang T, Yang X, Shen S, Yang Y, Wang W. Development and Validation of Artificial Neural Networks for Survival Prediction Model for Patients with Spontaneous Hepatocellular Carcinoma Rupture After Transcatheter Arterial Embolization. Cancer Management Res. 2021;13:7463–7477. doi:10.2147/CMAR.S328307
  • Li WH, Cheuk ECY, Kowk PCH, Cheung MT. Survival after transarterial embolization for spontaneous ruptured hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2009;16(4):508–512. doi:10.1007/s00534-009-0094-6
  • Zou J, Yuan J, Chen H, et al. Development of a prognostic score for recommended transarterial chemoembolization candidates with spontaneous rupture of hepatocellular carcinoma. J Gastrointest Oncol. 2022;13(3):1376–1383. doi:10.21037/jgo-22-531
  • Xie DY, Zhu K, Ren ZG, Zhou J, Fan J, Gao Q. A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights. Hepatobiliary Surgery Nutrition. 2023;12(2):216–228. doi:10.21037/hbsn-22-469
  • Huang X, Jia C, Xu L, et al. Survival of Patients Subjected to Hepatectomy After Spontaneous Rupture of Hepatocellular Carcinoma: a Meta-analysis of High-quality Propensity Score Matching Studies. Front Oncol. 2022;12:877091. doi:10.3389/fonc.2022.877091
  • Wu JJ, Zhu P, Zhang ZG, et al. Spontaneous rupture of hepatocellular carcinoma: optimal timing of partial hepatectomy. Eur j Surgical Oncol. 2019;45(10):1887–1894. doi:10.1016/j.ejso.2019.02.033
  • Xu X, Chen C, Liu Q, Huang X. A Meta-analysis of TAE/TACE Versus Emergency Surgery in the Treatment of Ruptured HCC. Cardiovascular Interventional Radiol. 2020;43(9):1263–1276. doi:10.1007/s00270-020-02514-5
  • Kerdsuknirun J, Vilaichone V, Vilaichone RK. Risk Factors and Prognosis of Spontaneously Ruptured Hepatocellular Carcinoma in Thailand. Asian Pacific j Cancer Prevention. 2018;19(12):3629–3634. doi:10.31557/APJCP.2018.19.12.3629